Alliance slams JAMA editors for push-back

A nonprofit group that monitors industry links to medical research called for the suspension of the top two editors of the Journal of the American Medical Association, and an investigation into allegations that they threatened a researcher who criticized a study published in the journal. Report

Suggested Articles

CG image of AstraZeneca's HQ
Pharma

AZ's Calquence posts sky-high CLL survival numbers

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

by Carly Helfand
fighting
Marketing

Keytruda's bladder cancer gene therapy rival wins in phase 3

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

by Angus Liu
Novartis headquarters
Pharma

FDA greenlights generics of Novartis' $3B MS star Gilenya

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

by Arlene Weintraub